Terms: = Ovarian cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
394 results:
1. Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Abrahão R; Brunson A; Ruddy KJ; Li Q; Li J; Ryder MM; Chubak J; Nichols HB; Sauder CAM; Gray MF; Hahn EE; Wun T; Keegan THM
Br J Cancer; 2024 Apr; 130(7):1166-1175. PubMed ID: 38332179
[TBL] [Abstract] [Full Text] [Related]
2. Intraperitoneal Therapy for ovarian cancer - Some Answers, More Questions, and Missed Opportunities.
Yeku OO
NEJM Evid; 2023 May; 2(5):EVIDe2300048. PubMed ID: 38320025
[TBL] [Abstract] [Full Text] [Related]
3. Reduced healthcare access contributes to delay of care in endometrial cancer.
Fife AJ; Najor AJ; Aspir TB; Haines KE; Vilardo NA; Isani SS; Cowan M; Gressel GM; Ye KQ; Nevadunsky NS; Kuo DY; Lin KY
Gynecol Oncol; 2024 Mar; 182():115-120. PubMed ID: 38262233
[TBL] [Abstract] [Full Text] [Related]
4. Hospital Volume and Quality of Care for Emergency Gynecologic Care.
Kalinowska V; Huang Y; Buckley A; St Clair CM; Pua T; Khoury-Collado F; Hou JY; Hershman DL; Wright JD
Obstet Gynecol; 2024 Feb; 143(2):303-311. PubMed ID: 38086058
[TBL] [Abstract] [Full Text] [Related]
5. Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients.
Barral Y; Borrás A; Carrillo P; Agustí I; Peralta S; Casals G; Fàbregues F; Guimerà M; Corral JM; Calafell JM; Redondo M; Glickman A; Rovira M; Adamo B; Ricart E; Trullàs DM
Clin Transl Oncol; 2024 May; 26(5):1129-1138. PubMed ID: 37872422
[TBL] [Abstract] [Full Text] [Related]
6. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
[TBL] [Abstract] [Full Text] [Related]
7. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer.
Newhouse R; Nelissen E; El-Shakankery KH; Rogozińska E; Bain E; Veiga S; Morrison J
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD006910. PubMed ID: 37407274
[TBL] [Abstract] [Full Text] [Related]
8. Uptake and Outcomes of Neoadjuvant Chemotherapy Among US Patients With Less Common Epithelial ovarian Carcinomas.
Matsuo K; Matsuzaki S; Maeda M; Rau AR; Yoshihara K; Tamura R; Shimada M; Machida H; Mikami M; Klar M; Roman LD; Wright JD; Sood AK; Gershenson DM
JAMA Netw Open; 2023 Jun; 6(6):e2318602. PubMed ID: 37326992
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and Safety of Stereotactic Body Radiation Therapy in Oligometastatic Uterine cancer (MITO-RT2/RAD): A Large, Real-World Study in Collaboration With Italian Association of Radiation Oncology, Multicenter Italian Trials in ovarian cancer, and Mario Negri Gynecologic Oncology Group Groups.
Macchia G; Pezzulla D; Campitelli M; Laliscia C; Fodor A; Bonome P; Draghini L; Ippolito E; De Sanctis V; Ferioli M; Titone F; Balcet V; Di Cataldo V; Russo D; Vicenzi L; Cossa S; Lucci S; Cilla S; Deodato F; Gambacorta MA; Scambia G; Morganti AG; Ferrandina G
Int J Radiat Oncol Biol Phys; 2023 Oct; 117(2):321-332. PubMed ID: 37150261
[TBL] [Abstract] [Full Text] [Related]
10. Muscle loss during cancer therapy is associated with poor outcomes in advanced ovarian cancer.
Polen-De C; Giri S; Fadadu P; Weaver A; Mcgree ME; Moynagh M; Takahashi N; Jatoi A; Lebrasseur NK; Cliby W; Williams G; Kumar A
J Natl Cancer Inst Monogr; 2023 May; 2023(61):43-48. PubMed ID: 37139982
[TBL] [Abstract] [Full Text] [Related]
11. Health services costs for ovarian cancer in Australia: Estimates from the 45 and Up Study.
Goldsbury DE; Vassallo A; Weber MF; Steinberg J; Webb PM; DeFazio A; Canfell K
PLoS One; 2023; 18(4):e0282851. PubMed ID: 37071628
[TBL] [Abstract] [Full Text] [Related]
12. Real-world outcomes associated with use of front-line bevacizumab in ovarian cancer.
Ethier JL; Kong W; MacKay HJ; McGee J; Booth CM
J Cancer Policy; 2023 Jun; 36():100421. PubMed ID: 37030536
[TBL] [Abstract] [Full Text] [Related]
13. Do Fertility Preservation Outcomes in Patients Diagnosed with Lymphoma Differ Based on cancer Stage?
Kocsuta V; Shah S; Lawson AK; Pavone ME
J Adolesc Young Adult Oncol; 2024 Apr; 13(2):300-306. PubMed ID: 36809174
[No Abstract] [Full Text] [Related]
14. Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Marathe PH; Dunkel IJ; Francis JH; Antal Z; Gobin YP; Abramson DH; Friedman DN
Ophthalmic Genet; 2022 Dec; 43(6):806-808. PubMed ID: 36695494
[TBL] [Abstract] [Full Text] [Related]
15. Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer: Going to the next level - A Memorial Sloan Kettering cancer Center study.
Kahn RM; McMinn E; Yeoshoua E; Boerner T; Zhou Q; Iasonos A; Long Roche K; Zivanovic O; Gardner GJ; Sonoda Y; O'Cearbhaill RE; Grisham RN; Tew W; Jones D; Huang J; Park BJ; Abu-Rustum NR; Chi DS
Gynecol Oncol; 2023 Mar; 170():46-53. PubMed ID: 36621269
[TBL] [Abstract] [Full Text] [Related]
16. Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Beltran-Bless AA; Clemons MJ; Fesl C; Greil R; Pond GR; Balic M; Vandermeer L; Bjelic-Radisic V; Singer CF; Steger GG; Helfgott R; Egle D; Sölkner L; Gampenrieder SP; Kacerovsky-Strobl S; Suppan C; Ritter M; Rinnerthaler G; Pfeiler G; Fohler H; Hlauschek D; Hilton J; Gnant M
Eur J Cancer; 2023 Feb; 180():108-116. PubMed ID: 36592505
[TBL] [Abstract] [Full Text] [Related]
17. The prognosis predictive score around primary debulking surgery (PPSP) improves diagnostic efficacy in predicting the prognosis of ovarian cancer.
Kawahara N; Kawaguchi R; Waki K; Maehana T; Yamanaka S; Yamada Y; Kimura F
Sci Rep; 2022 Dec; 12(1):22636. PubMed ID: 36587139
[TBL] [Abstract] [Full Text] [Related]
18. Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
Nelson AT; Harris AK; Watson D; Miniati D; Finch M; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Campos JM; Lederman S; Feltis BA; Vasta LM; Harney LA; Stewart DR; Dehner LP; Messinger YH; Hill DA; Schultz KAP
Cancer; 2023 Feb; 129(4):600-613. PubMed ID: 36541021
[TBL] [Abstract] [Full Text] [Related]
19. Analysis of the disease burden trend of malignant tumors of the female reproductive system in China from 2006 to 2020.
Han X; Wang Z; Huang D; Deng K; Wang Q; Li C; Zhu J
BMC Womens Health; 2022 Dec; 22(1):504. PubMed ID: 36476597
[TBL] [Abstract] [Full Text] [Related]
20. Early drug development in solid tumours: analysis of National cancer Institute-sponsored phase 1 trials.
Chihara D; Lin R; Flowers CR; Finnigan SR; Cordes LM; Fukuda Y; Huang EP; Rubinstein LV; Nastoupil LJ; Ivy SP; Doroshow JH; Takebe N
Lancet; 2022 Aug; 400(10351):512-521. PubMed ID: 35964611
[TBL] [Abstract] [Full Text] [Related]
[Next]
